Nano Dimension Ltd. (NNDM) Cash Flow Statement

The cumulative gap appears dominated by the $181.0 million net loss in 2025Q2, where operating cash outflow was only $46.0 million, implying roughly $135 million of write-downs or other non-cash charges in that quarter alone; the accounting loss therefore overstates the historical cash drain. However, the most recent quarters point the other way: in 2026Q2 operating cash outflow of $23.9 million exceeded the $6.5 million net loss (OCF/NI of 3.67), and a similar pattern holds in 2024Q3 and 2024Q4, suggesting accruals and working capital are now consuming more cash than the income statement records. Investors should treat the headline gap as a historical artifact of impairment rather than evidence of superior earnings quality.

Because capital expenditure is negligible relative to revenue, free cash flow tracks operating cash flow almost one-for-one, meaning the deterioration in 2026Q2 (-$23.9 million versus -$7.1 million in 2026Q1) is entirely an operating and working capital phenomenon rather than an investment cycle. This matters for the thesis of improving operating leverage: revenue has roughly doubled since 2024Q1, yet the cash loss per quarter has widened rather than narrowed, indicating overhead still outruns gross profit in cash terms, consistent with SG&A exceeding gross profit by roughly 2x in the latest quarter. The trajectory therefore suggests scaling has not yet reached a self-funding inflection point.

The magnitude of these swings is comparable to or larger than entire quarters of operating outflow, so reported operating cash flow appears highly sensitive to the timing of receivables, inventory and payables movements rather than to underlying trading performance. The reversal from a $7.1 million source in 2026Q1 to a $7.1 million use in 2026Q2 is notable because it coincided with the sharpest revenue step-up, which may indicate that growth is being absorbed by inventory or extended collections. The direction of this line should be monitored alongside revenue, since persistent working capital absorption alongside rising sales would tighten the cash runway materially.

With no dividends paid and acquisition activity limited to a single $210.9 million-thousand outflow in 2025Q4, buybacks represent essentially the entirety of disclosed capital deployment, which suggests management viewed the shares as cheap relative to the balance sheet cash rather than as a source of funding for operations. The buybacks have decelerated from $51.6 million in 2024Q1 to zero in 2025Q1 and 2025Q2, resuming at $5.0 million and $20.0 million in late 2025, a pattern that may indicate repurchases are being paced against liquidity. Whether this deployment was value-accretive depends on the cash position at each repurchase date, which warrants further investigation against the balance sheet data.

This cumulative gap means the reported loss base overstates the historical cash consumed by operations, which is a mildly reassuring signal for solvency over the period examined. However, the gap has been narrowing in the wrong direction recently: in 2026Q1 and 2026Q2 operating cash outflow exceeded the net loss, suggesting the cushion provided by non-cash charges is fading as the company runs off its impairment-related base. On this reading, the divergence is converging toward cash reality, and investors should not rely on the historical 2.7x OCF-to-net-income relationship as a forward guide.